Shin-Ichi Nakamoto

New development of a common glucosamine disaccharide intermediate with chemically differentiated two amino and six hydroxyl groups for lipid a syntheses and a formal synthesis of Salmonella mutant lipid A.

Abstract A formal synthesis of Salmonella mutant lipid A via the novel disaccharide intermediate bearing chemically differentiated two amino and six hydroxyl groups was described.

Combined effects of synthetic lipid A analogs and muramyl dipeptide on antitumor activity against meth a fibrosarcoma in mice

Combined effects of chemically synthesized lipid A analogs, the compound A-171 (acylglucosamine-4-phosphate with (R)-3-hydroxytetradecanoyl and (R)-3-hydroxytetradecanoyloxy]tetradecanoyl group at the C-2 and C-3 positions), or the compound A-172 (with (R)-3-hydroxytetradecanoyloxy]tetradecanoyl and (R)-3-tetradecanoyloxytetradecanoyl group at the C-2 and C-3 positions), and muramyl dipeptide (MDP) on antitumor activity against Meth A fibrosarcoma, were examined. Meth A fibrosarcoma cells (5 X 10(5)) were inoculated intradermally into BALB/c mice on day 0, compound A-172 and/or MDP were administered intravenously (i.v.) on day 7. Although the antitumor activity by single i.v. injection of A-172 (50 micrograms/mouse) with MDP (10 micrograms) was weaker than that of 50 micrograms of synthetic lipid A analogs (506), or 10 micrograms of bacterial lipopolysaccharide (LPS) with MDP, A-172 alone and with MDP exhibited tumor inhibition rates of 49.0 and 70.6%, respectively. When A-171 (50 micrograms) with MDP (10 micrograms) was administered i.v. twice (days 7 and 10) into mice inoculated Meth A fibrosarcoma, two of five mice caused complete tumor regression. Furthermore, L929 cell lysis by the combination of A-171, A-172 with MDP was higher than that by the analogs or MDP alone, suggesting that the lipid A analogs of monosaccharide type as well as LPS are able to enhance the production of tumor necrosis factor in the presence of MDP.

A new synthesis of lipid Y by the use of chemoselective debenzylation as a key step

Synthese du lipide Y (phosphate de (desoxy-2 O-[hydroxy-2 myristoylamino]-2 O-[palmitoyloxy-2 myristoyl]-3 glucopyranosyle))